RESOLUTE-DC for MODEL MEDICINES
What was lobbied
2 issue areas, each in the filer's own words, with who lobbied on it and where.
Medical/Disease Research/Clinical Labs MED
Supporting Model Medicines as it seeks federal funding to further develop, receive FDA approvals for, and begin manufacturing for their drug, MDL-001, which has been identified as a potential best-in-class, pan-antiviral drug with treatment paradigm changing potential. We are approachingcongressional committees that authorize and fund HHS/NIH programs and DARPA (at DOD). We also are approaching political appointees in thoseagencies, as possible.
| Lobbyist | Covered position, as disclosed |
|---|---|
| GREG GOLDNER New | — |
Health Issues HCR
Supporting Model Medicines as it seeks federal funding to further develop, receive FDA approvals for, and begin manufacturing for their drug, MDL-001, which has been identified as a potential best-in-class, pan-antiviral drug with treatment paradigm changing potential. We are approachingcongressional committees that authorize and fund HHS/NIH programs and DARPA (at DOD). We also are approaching political appointees in thoseagencies, as possible.
| Lobbyist | Covered position, as disclosed |
|---|---|
| GREG GOLDNER New | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.